Determinants of Quality of Life in a Psoriasis Population in Northern Sweden

Uttjek, Margaretha; Dufåker, Mona; Nygren, Lennart; Stenberg, Berndt

doi:10.1080/00015550310015833

Cited by 28 publications

(40 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Also, lower HRQoL was found in female patients [12]. However, the result of de Korte et al [11] that patients with severer psoriasis had lower HRQoL was consistent with results of other studies [12,13,14,15]. Other variables found to be associated with lower HRQoL were depression, low income, smoking, lesions on the face and genitals, pruritus and dissatisfaction with treatment [13].…”

Section: Introductionsupporting

confidence: 73%

Time Needed for Treatment Is the Major Predictor of Quality of Life in Psoriasis

Blome¹,

Simianer²,

Purwins³

et al. 2010

Dermatology

View full text Add to dashboard Cite

Background: The literature on predictors of health-related quality of life in psoriasis is inconsistent. Objective: To assess potential predictors of quality of life in psoriasis. Methods: In a cross-sectional study involving 130 dermatological practices and outpatient clinics, data of 1,210 patients with psoriasis were collected. Quality of life was evaluated using the Dermatology Life Quality Index. Medical history, clinical and sociodemographic characteristics, therapy and health care features were used as independent variables in a backward multiple regression analysis. Results: Twelve predictors were included in the model explaining 38% of variance in quality of life. The strongest predictor was daily treatment time (β = 0.30), followed by patient-defined treatment benefit (β = –0.18), disease severity (β = 0.19) and treatment satisfaction (β = –0.16). Conclusion: Treatment burden requires special attention when quality of life in psoriasis is to be improved. Since the larger part of variance is left unexplained, further factors predicting quality of life have yet to be detected.

show abstract

Section: Introductionsupporting

confidence: 73%

Time Needed for Treatment Is the Major Predictor of Quality of Life in Psoriasis

Blome¹,

Simianer²,

Purwins³

et al. 2010

Dermatology

View full text Add to dashboard Cite

show abstract

“…Some variability occurred in regional representation, particularly with MarketScan. Psoriasis patients in both datasets had demographic profiles consistent with the literature from multi-site observational studies on ambulatory psoriasis patients, although they tended to be older, depending on the dataset [25,26,27,28]. Patients in IMS Health were younger than those from MarketScan (table 3), and in both datasets the patients with psoriasis were older and more likely to be male than in the overall population from which they were chosen [20].…”

Section: Resultssupporting

confidence: 48%

Cardiovascular Disease and Risk Factors among Psoriasis Patients in Two US Healthcare Databases, 2001–2002

et al. 2008

View full text Add to dashboard Cite

Background: Cardiovascular diseases or risk factors (CVDR) seem to be more common in psoriasis patients than in the general population. Objective: We assessed the relationship of psoriasis with CVDR by analysis of healthcare claims data using a cross-sectional, prevalence-based study design. Patients and Methods: The IMS Health and MarketScan® claims databases were used to identify adults with psoriasis diagnostic codes. Non-psoriasis controls were matched 3:1 based on age, gender, census region and previous medical insurance coverage. Odds ratios evaluated the relative prevalence of CVDR, and Mantel-Haenszel confidence intervals were estimated. Results: CVDR prevalence was generally higher in psoriasis patients than controls in both datasets. Odds ratios for atherosclerosis, congestive heart failure, type 2 diabetes, and peripheral vascular disease were ≧1.20 for psoriasis patients. Elevated disease severity was associated with a higher rate of CVDR, but varied somewhat by dataset and condition. Conclusions: Elevated CVDR rates were found in psoriasis patients compared with controls. This pattern merits further examination.

show abstract

“…Highly impaired HRQL is associated with decreased treatment satisfaction and adherence [15,16,17,18]. HRQL is significantly more impaired in hospitalized patients than in outpatients [19].…”

Section: Introductionmentioning

confidence: 99%

Effectiveness of Inpatient Treatment on Quality of Life and Clinical Disease Severity in Atopic Dermatitis and Psoriasis Vulgaris – A Prospective Study

et al. 2006

View full text Add to dashboard Cite

Background: Financial constraints challenge evidence of the effectiveness of dermatological inpatient management. Objective: To evaluate the effectiveness of hospitalization in atopic dermatitis and psoriasis regarding initial and sustained benefits. Methods: Prospective study on adults with psoriasis vulgaris (n = 22) and atopic dermatitis (n = 14). At admission, discharge, and 3 months after discharge, validated outcomes of objective and subjective disease severity were assessed by trained investigators. Results: Hospitalization resulted in substantial benefit in quality of life and clinical disease severity. Looking at mean scores, the observed benefit appeared stable until 3-month follow-up. The analysis of individual patient data revealed significant changes in disease severity between discharge and 3-month follow-up with some patients relapsing, others further improving. Reasons for hospitalization and treatment performed were not related to sustained benefit. Conclusions: In psoriasis vulgaris and atopic dermatitis, hospitalization effectively improved quality of life and clinical disease severity. Further research should focus on prognostic factors for sustained improvement.

show abstract

Determinants of Quality of Life in a Psoriasis Population in Northern Sweden

Cited by 28 publications

References 22 publications

Time Needed for Treatment Is the Major Predictor of Quality of Life in Psoriasis

Time Needed for Treatment Is the Major Predictor of Quality of Life in Psoriasis

Cardiovascular Disease and Risk Factors among Psoriasis Patients in Two US Healthcare Databases, 2001–2002

Effectiveness of Inpatient Treatment on Quality of Life and Clinical Disease Severity in Atopic Dermatitis and Psoriasis Vulgaris – A Prospective Study

Contact Info

Product

Resources

About